Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Punnaka Pongpanich"'
Autor:
Punnaka Pongpanich, Parima Hirunwiwatkul, Supharat Jariyakosol, Buravej Assavapongpaiboon, Supaporn Krittanupong, Wasee Tulvatana
Publikováno v:
iScience, Vol 27, Iss 6, Pp 109877- (2024)
Summary: This study investigated telemedicine reliability and usability in evaluating facial dystonia grading and treatment complications. Eighty-two telemedicine recordings from 43 adults with blepharospasm (12, 28%) and hemifacial spasm (31, 72%) w
Externí odkaz:
https://doaj.org/article/1d7a0bfa90304eca939eb179bc7c9cb2
Autor:
Parima Hirunwiwatkul, Punnaka Pongpanich, Wasee Tulvatana, Supharat Jariyakosol, Warongporn Phuenpathom, Supaporn Krittanupong, Ruttanabhorn Chonramak, Tidarat Pichedvanichok, Roongroj Bhidayasiri, Chaichana Nimnuan
Publikováno v:
International Journal of Telerehabilitation, Vol 15, Iss 2 (2023)
This cross-sectional validation study aimed to translate, cross-culturally adapt, and investigate the psychometric properties of a Thai version of the Telehealth Usability Questionnaire (T-TUQ). Two hundred and ten Thai participants, mean age of 61.2
Externí odkaz:
https://doaj.org/article/6e5cf077a55041268a65ff8029ea7ac4
Autor:
Punnaka Pongpanich, Parima Hirunwiwatkul, Supharat Jariyakosol, Buravej Assavapongpaiboon, Supaporn Krittanupong, Wasee Tulvatana
This study aimed to investigate telemedicine reliability and usability for facial dystonia. Eighty-two telemedicine recordings from 43 adults with blepharospasm (12,27.9%) and hemifacial spasm (31,72.1%) were obtained (mean age 64.5+9.3 years, 32 fem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc01c743a3e58603f5c85967da9f5322
https://doi.org/10.21203/rs.3.rs-2871075/v1
https://doi.org/10.21203/rs.3.rs-2871075/v1
Autor:
Kullaya Takkavatakarn, Somchai Eiam-Ong, Paweena Susantitaphong, Pasvich Pitakpaiboonkul, Punnaka Pongpanich, Kearkiat Praditpornsilpa
Publikováno v:
International Urology and Nephrology. 50:2261-2278
The prevalence of hypertension and its associated complications are markedly growing. Most patients need more than one drug to achieve blood pressure (BP) target. However, most guidelines only focus on the first-line treatment. We conducted a meta-an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2332e5a981ac293e6b166a8a266e516f
https://doi.org/10.1007/s11255-018-1991-x
https://doi.org/10.1007/s11255-018-1991-x